Through the expression of genes in Oncogenic pathways such as TP53, EGFR, CTNNB1, etc., to maintain Oncogenic signaling, thereby forming a tumor immune-suppressive microenvironment to promote immune escape [40, 65]. The gene discussed is EGFR; the disease is neoplasm.